Search bioRxiv⌕ Search

Biology subjects

Achanta, N.

Publications and source records attributed to Achanta, N..

2 recordsLinked to original sources

Mitochondrial and bioenergetic processes are enriched in large-but are reciprocally depleted in small extracellular vesicles

Extracellular vesicles (EVs) are a promising class of drug delivery carriers for a broad range of therapeutic applications. We have previously demonstrated that brain endothelial cell (BEC)-derived large EVs (>200 nm in particle diameter) increased mitochondrial function in recipient BECs and improved therapeutic outcomes in a mouse model of ischemic stroke. In the current study, we demonstrate using size-resolved quantitative proteomics and gene-set enrichment analysis that mitochondrial and bioenergetic processes are enriched in large- but are reciprocally depleted in small EVs (exosomes, <200 nm in particle diameter). These results are striking and reveal the selective packaging of mitochondrial cargo in large but not small EVs. These strong mechanistic data anchor the rationale for the continued development of large EV mitochondria as a potential approach for the treatment of multiple diseases associated with mitochondrial dysfunction.

bioengineering↗

Bioreactor cultures of brain endothelial cells produce extracellular vesicles with comparable characteristics as that of batch cultures

Our prior works have demonstrated the therapeutic potential extracellular vesicles (EVs) derived from batch cultures of brain endothelial cells (BECs) owing to their ability to transfer mitochondria to injured recipient cells. However, conventional batch/flask cultures limit scalable and reproducible production of EVs. Here, we evaluated a CELLine AD1000 bioreactor as a platform for sustained production of EVs from mouse b.End3 BECs and compared bioreactor-derived (BR) EVs with EVs obtained conventional batch cultures (BT). Large EVs (lEVs) and small (sEVs) were isolated using a sequential centrifugation protocol and were characterized using dynamic light scattering, nanoparticle tracking analysis, microBCA assay, western blotting, proteomics analysis, and their ability to rescue bioenergetics in oxygen-glucose deprived (OGD) BECs. Bioreactor cultures maintained high cell viabilities (~90%) for up to eight weeks and produced approximately three- to four-fold greater EV protein yields than batch cultures. BR EVs showed reproducible particle characteristics consistent with EV subtypes derived from BT cultures. CD63, CD9 and Arf6 were detected in EV fractions, whereas the mitochondrial outer-membrane protein TOMM20 was enriched in lEVs. Proteomic analyses revealed that bioreactor-derived lEVs retained the mitochondrial cargo signature observed in batch-derived lEVs. Both bioreactor and batch EVs restored relative ATP levels in ODG-exposed BECs. These findings suggest that bioreactor BEC cultures are a scalable approach for generating functionally active BEC-EVs for downstream characterization and therapeutic development.

bioengineering↗